Copyright © 2016 American Chemical Society
October 24, 2016 Cover
Volume 94, Issue 42
Volume 94, Issue 42
Or: How the pharmaceutical research sector learned to stop worrying and love the cloud
Credit: iStockphoto
» Full Article
October 24, 2016 Issue
Volume 94, Issue 42
October 24, 2016 Issue, Vol. 94 | Iss. 42
Or: How the pharmaceutical research sector learned to stop worrying and love the cloud
(pp. 26-30)
Features
Science & Technology
Organic ligands help sequester and separate inorganic ions in mining and nuclear waste treatment (pp. 18-19)
Government & Policy
Attacks and infighting from the previously congenial committee worry the science community (pp. 20-21)
News of the Week
Interruptores endocrinos: ¿cuál es el coste para los humanos?
Un estudio calcula el gasto en sanidad y las pérdidas de ingresos causados por niveles bajos de exposición a determinadas sustancias químicas sintéticas
(p.5)Putting a human cost on endocrine disruptors
Study quantifies health care spending and lost wages stemming from low-level exposures to certain synthetic chemicals
(p.5)Sticking it to the internet of things
Futuristic “smart” decals rely on conventional semiconductor materials and processing, but also 3-D printing
(p.7)Unusual hydrogen bond plays a bigger role in proteins than chemists realized
Interaction affects 94% of all proteins, study shows
(p.7)Mercury from WWII submarine wreck pollutes sediments off Norway
But the discharge probably has not contaminated the marine food web
(p.8)One-step method determines reaction products’ yield, enantiomeric excess, and configuration
Technique accelerates evaluation of amine-containing chiral compounds
(p.8)Fatal explosion hits BASF’s Ludwigshafen site
Two workers dead, one missing; 20 plants shut down or partially running
(p.13)Perlara signs rare disease pact with Novartis
Start-up seeks to advance its unusual business model with a big pharma partner
(p.13)Shell bids for cellulosic ethanol plant
Refiner may snag large Abengoa facility for $26 million
(p.13)Departments
Business
Solenis CEO Panichella says bolt-on acquisitions and new technology will help invigorate the firm
(pp. 22-23)
Or: How the pharmaceutical research sector learned to stop worrying and love the cloud
(pp. 26-30)Concentrates
(pp. 14-15)
(pp. 14-15)- Dow, DuPont may shed units to ease big deal
- Celanese will buy Italian compounder
- Jennifer Abril to head SOCMA
- Air Liquide builds ingredients facility
- Ferro adds two pigment businesses
- Dutch chemical firms harness the wind
- Japanese firms link China electrolytes
- Giant solar farm planned for Nevada
- Merck ups Spanish drug capacity 50%
- Money raised by industrial, drug funds
- Vertex expands cystic fibrosis pact
- ADC Therapeutics raises big money for drug conjugates
- Business Roundup
ACS News
First-generation college students share ACS’s impact
(p.34)
Government & Policy
Attacks and infighting from the previously congenial committee worry the science community
(pp. 20-21)Education
Professor adopted alternative grading strategy to ensure his students master the essentials of organic chemistry
(pp. 24-25)
Science & Technology
Organic ligands help sequester and separate inorganic ions in mining and nuclear waste treatment
(pp. 18-19)Concentrates(pp. 10-11)
(pp. 10-11)- Coffee-ring effect produces chemical patterns
- Chilling tomatoes blocks production of flavor-making enzymes
- Engineered plants produce malaria drug efficiently
- Attaching ‘unlinkable’ drugs to antibodies
- Superhydrophobic packaging protects water-sensitive catalysts
- Tapping into the human microbiome yields MRSA-active antibiotics
- Concrete skin detects cracking and chemical leaks